FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040379370> ?p ?o ?g. }

• W2040379370 endingPage "295" @default.
• W2040379370 startingPage "286" @default.
• W2040379370 abstract "Highly relevant mouse models of human neuroblastoma (NB) are needed to evaluate new therapeutic strategies against NB. In this study, we characterized transgenic mice with bilateral adrenal tumors. On the basis of information from the tumoral gene expression profiles, we examined the antitumor effects of unencapsulated and liposomal doxorubicin (DXR), alone and in combination with gefitinib, on adrenal NB. We showed that intravenous injection of unencapsulated or liposomal DXR alone inhibited tumor growth in a dose-dependent manner, as assessed by magnetic resonance imaging (MRI). However, liposomal DXR did not exhibit greater antitumor effect than unencapsulated DXR. Immunohistochemical analysis revealed that the adrenal tumor vasculature with abundant pericyte coverage was a less leaky structure for liposomes. Combination therapy with unencapsulated or liposomal DXR plus gefitinib strongly suppressed tumor growth and delayed tumor regrowth than treatment with unencapsulated or liposomal DXR alone, even at a lower dose of DXR. Dynamic contrast-enhanced MRI analysis revealed that gefitinib treatment increased blood flow in the tumor, indicating that gefitinib treatment changes the tumor vascular environment in a manner that may increase the antitumor effect of DXR. In conclusion, the combination of gefitinib and DXR induces growth inhibition of adrenal NBs in transgenic mice. These findings will provide helpful insights into new treatments for NB." @default.
• W2040379370 created "2016-06-24" @default.
• W2040379370 creator A5038246750 @default.
• W2040379370 creator A5048052985 @default.
• W2040379370 creator A5052859982 @default.
• W2040379370 creator A5053226336 @default.
• W2040379370 creator A5061906026 @default.
• W2040379370 date "2013-04-02" @default.
• W2040379370 modified "2023-09-25" @default.
• W2040379370 title "Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma" @default.
• W2040379370 cites W1936102867 @default.
• W2040379370 cites W1968762000 @default.
• W2040379370 cites W1972457909 @default.
• W2040379370 cites W1990489847 @default.
• W2040379370 cites W2003552025 @default.
• W2040379370 cites W2006068081 @default.
• W2040379370 cites W2016065032 @default.
• W2040379370 cites W2021598375 @default.
• W2040379370 cites W2022384016 @default.
• W2040379370 cites W2039037459 @default.
• W2040379370 cites W2048517100 @default.
• W2040379370 cites W2058192227 @default.
• W2040379370 cites W2058879480 @default.
• W2040379370 cites W2072802467 @default.
• W2040379370 cites W2075964820 @default.
• W2040379370 cites W2093051100 @default.
• W2040379370 cites W2094935740 @default.
• W2040379370 cites W2106663496 @default.
• W2040379370 cites W2107535776 @default.
• W2040379370 cites W2132257982 @default.
• W2040379370 cites W2147457741 @default.
• W2040379370 cites W2147903025 @default.
• W2040379370 cites W2154324465 @default.
• W2040379370 cites W2156609950 @default.
• W2040379370 cites W2157952351 @default.
• W2040379370 cites W2158688408 @default.
• W2040379370 cites W2167319223 @default.
• W2040379370 cites W2305149488 @default.
• W2040379370 cites W2323591151 @default.
• W2040379370 cites W4211031423 @default.
• W2040379370 doi "https://doi.org/10.1002/cam4.76" @default.
• W2040379370 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3699840" @default.
• W2040379370 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23930205" @default.
• W2040379370 hasPublicationYear "2013" @default.
• W2040379370 type Work @default.
• W2040379370 sameAs 2040379370 @default.
• W2040379370 citedByCount "13" @default.
• W2040379370 countsByYear W20403793702013 @default.
• W2040379370 countsByYear W20403793702014 @default.
• W2040379370 countsByYear W20403793702015 @default.
• W2040379370 countsByYear W20403793702018 @default.
• W2040379370 countsByYear W20403793702019 @default.
• W2040379370 crossrefType "journal-article" @default.
• W2040379370 hasAuthorship W2040379370A5038246750 @default.
• W2040379370 hasAuthorship W2040379370A5048052985 @default.
• W2040379370 hasAuthorship W2040379370A5052859982 @default.
• W2040379370 hasAuthorship W2040379370A5053226336 @default.
• W2040379370 hasAuthorship W2040379370A5061906026 @default.
• W2040379370 hasBestOaLocation W20403793701 @default.
• W2040379370 hasConcept C102230213 @default.
• W2040379370 hasConcept C104317684 @default.
• W2040379370 hasConcept C121608353 @default.
• W2040379370 hasConcept C126322002 @default.
• W2040379370 hasConcept C141035611 @default.
• W2040379370 hasConcept C2776694085 @default.
• W2040379370 hasConcept C2776715637 @default.
• W2040379370 hasConcept C2779438470 @default.
• W2040379370 hasConcept C2780580887 @default.
• W2040379370 hasConcept C2781303535 @default.
• W2040379370 hasConcept C502942594 @default.
• W2040379370 hasConcept C54355233 @default.
• W2040379370 hasConcept C55493867 @default.
• W2040379370 hasConcept C71924100 @default.
• W2040379370 hasConcept C81885089 @default.
• W2040379370 hasConcept C86803240 @default.
• W2040379370 hasConcept C98274493 @default.
• W2040379370 hasConceptScore W2040379370C102230213 @default.
• W2040379370 hasConceptScore W2040379370C104317684 @default.
• W2040379370 hasConceptScore W2040379370C121608353 @default.
• W2040379370 hasConceptScore W2040379370C126322002 @default.
• W2040379370 hasConceptScore W2040379370C141035611 @default.
• W2040379370 hasConceptScore W2040379370C2776694085 @default.
• W2040379370 hasConceptScore W2040379370C2776715637 @default.
• W2040379370 hasConceptScore W2040379370C2779438470 @default.
• W2040379370 hasConceptScore W2040379370C2780580887 @default.
• W2040379370 hasConceptScore W2040379370C2781303535 @default.
• W2040379370 hasConceptScore W2040379370C502942594 @default.
• W2040379370 hasConceptScore W2040379370C54355233 @default.
• W2040379370 hasConceptScore W2040379370C55493867 @default.
• W2040379370 hasConceptScore W2040379370C71924100 @default.
• W2040379370 hasConceptScore W2040379370C81885089 @default.
• W2040379370 hasConceptScore W2040379370C86803240 @default.
• W2040379370 hasConceptScore W2040379370C98274493 @default.
• W2040379370 hasIssue "3" @default.
• W2040379370 hasLocation W20403793701 @default.
• W2040379370 hasLocation W20403793702 @default.
• W2040379370 hasLocation W20403793703 @default.
• W2040379370 hasLocation W20403793704 @default.

• next